ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Other Working Capital Changes of -$31146.0 for Q1 2026, down 1179.96% YoY from $2884.0 in Q1 2025, and up 77.71% sequentially from -$139740.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Other Working Capital Changes across 11 years of filings, most recently posting -$31146.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 1179.96% year-over-year to -$31146.0; the TTM figure through Mar 2026 stood at -$197943.0 (up 58.69% YoY), while the FY2025 annual figure was $42.0, up 7.69% from the prior year.
- Other Working Capital Changes improved to -$31146.0 in Q1 2026, from -$139740.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for NDRA reached as high as $47769.0 in Q2 2022 and fell as low as -$286597.0 in Q1 2022.
- The 5-year median for Other Working Capital Changes is $38.0 (2024), against an average of -$44710.5.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes jumped 864.55% — and 2026, when it tumbled 1179.96%.
- A 5-year view of Other Working Capital Changes shows it stood at -$257481.0 in 2022, then rose by 24.42% to -$194608.0 in 2023, then surged by 84.61% to -$29941.0 in 2024, then slumped by 366.72% to -$139740.0 in 2025, then surged by 77.71% to -$31146.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$31146.0, -$139740.0, and $12.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31,146.00 |
| Mar 31, 2026 | -31,146.00 |
| Dec 31, 2025 | -139,740.00 |
| Dec 31, 2025 | -139,740.00 |
| Sep 30, 2025 | 12.00 |
| Sep 30, 2025 | 12.00 |
| Jun 30, 2025 | 12.00 |
| Jun 30, 2025 | 12.00 |
| Mar 31, 2025 | 2,884.00 |
| Mar 31, 2025 | 2,884.00 |
| Dec 31, 2024 | -29,941.00 |
| Dec 31, 2024 | -29,941.00 |
| Sep 30, 2024 | 38.00 |
| Sep 30, 2024 | 38.00 |
| Jun 30, 2024 | 399.00 |
| Jun 30, 2024 | 399.00 |
| Mar 31, 2024 | -42,609.00 |
| Mar 31, 2024 | -42,609.00 |
| Dec 31, 2023 | -194,608.00 |
| Dec 31, 2023 | -194,608.00 |